Osborne Clarke advises a range of life sciences clients, from scale-ups to multinational corporations, on various EU regulatory and quality matters. Their expertise extends to medical device, product and digital health mandates. The team assists with EU-wide quality systems, regulatory standards, market entry strategies and good manufacturing practices. Practice head Vladimir Murovec focuses exclusively on the healthcare sector and is recognised for his compliance expertise. Other notable names include Louis Hoffreumon and Fjoralba Spahiu.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘The individuals are collegial, reliable and lovely to work with.’
- ‘Osborne Clarke’s EU compliance team in Brussels is widely recognised in life sciences for the deep regulatory know-how and a practical, solutions-driven approach to issues. This is true across our full product portfolio (pharma, medtech, and food supplements).'
- ‘Vladimir Murovec is our go-to person for all things regulatory or compliance. He stands out for being not just sharp on the law, but also down-to-earth and approachable — even with complex topics like new digital health rules or the quirks of EU device regulations. He really knows his stuff.'
- ‘The team is knowledgeable and well-versed in recent regulatory developments. They are flexible and able to jump into projects with tight timelines and deliver terrific work product.’
- ‘Responsive to the complex pharmaceutical regulatory issues in a precise way.’
- ‘The EU regulatory team at Osborne Clarke is highly knowledgeable and very easy to work with. What sets them apart is their ability to translate complicated legislation and guidance into practical advice that works for a pharma business. On top of their EU regulatory capabilities, they also have a solid expertise in cross-border pharma compliance (HCP interactions) matters and digital health.’
Key clients
- Alain Afflelou International
- Amgen
- ATB Therapeutics
- Baxter (Vantive)
- Bepharbel Manufacturing
- BioSenic
- Bluefin Biomedicine, Inc.
- Chemviron
- Circular Innovation Fund
- CooperVision
- Danone
- Diageo
Work highlights
Advised Samsara Vision, Inc. on EU-wide regulatory issues for supply chain and cross-border registrations, and provided multi-jurisdictional guidance on national rules for KOL engagement, tenders, clinical investigations, and consulting arrangements across Europe.
Advised Grifols on the ethical and healthcare compliance considerations involved in cross-border interactions with healthcare professionals participating in congresses, site visits, and consulting activities at scientific events in Europe.
Advised Puratos Group on establishing a compliance framework for EU and International Nagoya Protocol regulations, developing decision tools and guidance to help their global R&D teams navigate complex cross-border requirements for accessing and using genetic resources.
Lawyers
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Practice head
Vladimir Murovec
Other key lawyers
Fjoralba Spahiu; Louis Hoffreumon